Key Insights
The global exoskeleton market is experiencing robust growth, driven by the increasing prevalence of neurological disorders, spinal cord injuries, and the rising demand for rehabilitation solutions. The market, valued at approximately $1.5 billion in 2025, is projected to witness a compound annual growth rate (CAGR) of 12.5% from 2025 to 2033. This expansion is fueled by technological advancements leading to lighter, more user-friendly, and cost-effective exoskeletons. The increasing adoption of exoskeletons across various sectors, including healthcare, military, and industrial applications, further contributes to market growth. The rehabilitation segment currently dominates the market due to a growing aging population and the consequent rise in age-related mobility impairments. However, the augmentation segment is poised for significant growth in the coming years, driven by increasing demand for assistive technologies in industrial settings to improve worker productivity and reduce workplace injuries. Geographic analysis indicates that North America currently holds the largest market share, owing to early adoption of advanced technologies and robust healthcare infrastructure. However, the Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period, fueled by rising healthcare expenditure and a burgeoning elderly population in countries like China and India. Competition in the market is intense, with established players like Parker-Hannifin and Ekso Bionics competing with emerging innovative companies like B-Temia and Gogoa Mobility Robots. Future growth will be influenced by factors such as regulatory approvals, technological advancements in areas such as artificial intelligence and sensor technology, and the affordability of exoskeletons.
The segmentation of the market by treatment type (rehabilitation and augmentation) and body part type (upper and lower body) provides further insights into the market dynamics. The upper body exoskeleton segment holds a substantial share, largely driven by applications in stroke rehabilitation and assistance with activities of daily living. However, the lower body segment is showing accelerated growth due to its applications in mobility assistance for individuals with paralysis and other mobility impairments. The product type segmentation (stationary and mobile) highlights the increasing popularity of mobile exoskeletons, owing to their greater versatility and potential for wider application in diverse environments. Challenges include high initial costs associated with exoskeleton technology, the need for skilled professionals for proper fitting and training, and potential concerns regarding safety and efficacy. However, ongoing technological improvements and decreasing manufacturing costs are gradually mitigating these limitations, further bolstering market expansion.

Exoskeleton Industry Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the global exoskeleton industry, covering market dynamics, growth trends, regional segmentation, product landscape, and key players. The study period spans from 2019 to 2033, with 2025 serving as the base and estimated year. The forecast period is 2025-2033, and the historical period covers 2019-2024. The report segments the market by treatment type (Rehabilitation, Augmentation), body part type (Upper Body, Lower Body), and product type (Stationary, Mobile), offering a granular understanding of this rapidly evolving sector. The market size is valued in million units.
Exoskeleton Industry Market Dynamics & Structure
The exoskeleton market is characterized by moderate concentration, with several key players vying for market share. Technological innovation, particularly in areas like lightweight materials, advanced sensors, and AI-driven control systems, is a major driver. Regulatory frameworks, varying across regions, impact market entry and adoption. Competitive substitutes, such as traditional assistive devices, exert pressure. The end-user demographic is expanding to include healthcare professionals, industrial workers, and military personnel. M&A activity has been moderate, with strategic acquisitions aiming to enhance technology portfolios and expand market reach.
- Market Concentration: Moderately concentrated, with top 5 players holding approximately xx% market share in 2025.
- Technological Innovation: Focus on miniaturization, improved power efficiency, and intuitive interfaces.
- Regulatory Landscape: Varying approval processes across different geographies create hurdles for market expansion.
- Competitive Substitutes: Traditional mobility aids present competition, especially in the rehabilitation segment.
- End-User Demographics: Expanding to include industrial settings and military applications beyond healthcare.
- M&A Activity: xx major M&A deals observed between 2019 and 2024, primarily focused on technology integration.
Exoskeleton Industry Growth Trends & Insights
The global exoskeleton market is experiencing significant growth, driven by technological advancements, increasing geriatric population, rising prevalence of neurological disorders, and growing demand from industrial sectors. The market size is projected to reach xx million units by 2033, registering a CAGR of xx% during the forecast period. Adoption rates are increasing across various applications, particularly in rehabilitation and industrial settings. Technological disruptions, such as the integration of AI and advanced sensors, are shaping product features and functionalities. Consumer behavior is shifting towards more comfortable, user-friendly, and cost-effective exoskeletons. Market penetration is expected to increase from xx% in 2025 to xx% by 2033, driven by expanding applications and improving affordability.

Dominant Regions, Countries, or Segments in Exoskeleton Industry
North America currently holds the largest market share, driven by high healthcare expenditure, technological advancements, and robust regulatory frameworks. Within treatment types, the rehabilitation segment dominates, owing to a growing elderly population and rising incidence of neurological disorders. In terms of body part type, the lower body segment accounts for the largest market share due to higher demand for mobility assistance. The mobile exoskeleton product type is currently leading, owing to the increased flexibility and application in various settings. However, the stationary segment is showing promising growth potential with the advancement of technologies.
- North America: High healthcare expenditure and technological advancements fuel market growth.
- Europe: Growing adoption in rehabilitation centers and industrial settings.
- Asia Pacific: Significant growth potential driven by increasing healthcare spending and a large aging population.
- Rehabilitation Segment: Dominates the market due to the increasing prevalence of neurological disorders and aging population.
- Lower Body Exoskeletons: Highest demand due to mobility assistance needs.
- Mobile Exoskeletons: Lead in market share due to increased versatility and application across various settings.
Exoskeleton Industry Product Landscape
Exoskeleton technology continues to evolve, with advancements in lightweight materials, improved power sources, and more intuitive control systems. Products now offer enhanced user comfort, improved dexterity, and more precise movement control. Unique selling propositions include features like customizable interfaces, advanced sensors for real-time feedback, and integrated rehabilitation software. Technological advancements are resulting in more robust, reliable, and adaptable exoskeletons for various applications.
Key Drivers, Barriers & Challenges in Exoskeleton Industry
Key Drivers:
- Technological Advancements: Miniaturization, improved power efficiency, and AI integration.
- Rising Healthcare Expenditure: Increased funding for rehabilitation and assistive technologies.
- Growing Geriatric Population: Increased demand for mobility assistance.
Challenges & Restraints:
- High Cost: Limiting widespread adoption, particularly in developing countries.
- Regulatory Hurdles: Varying approval processes create market entry barriers.
- Supply Chain Disruptions: Impacting manufacturing and distribution.
- Competition: Existing assistive devices and emerging technologies pose a challenge.
Emerging Opportunities in Exoskeleton Industry
Untapped markets in developing countries present significant growth potential. Innovative applications in areas like agriculture and logistics are emerging. Evolving consumer preferences toward personalized and customizable exoskeletons are driving product development. Integration with virtual reality and other assistive technologies presents additional avenues for expansion.
Growth Accelerators in the Exoskeleton Industry
Technological breakthroughs in areas like battery technology and advanced materials are crucial. Strategic partnerships between technology developers, healthcare providers, and industrial companies can accelerate market penetration. Expansion into new applications, such as disaster relief and construction, will drive long-term growth.
Key Players Shaping the Exoskeleton Industry Market
- Parker-Hannifin Corp
- B-Temia Inc
- Rewalk Robotics
- Rehab-Robotics Company Limited
- Gogoa Mobility Robots
- Bioservo Technologies AB
- Bionik Laboratories Corp
- Cyberdyne Inc
- Ekso Bionics Holdings
- Bioness Inc
Notable Milestones in Exoskeleton Industry Sector
- 2020: FDA approval of a new exoskeleton for stroke rehabilitation.
- 2021: Launch of a lightweight exoskeleton for industrial applications.
- 2022: Major investment in a company developing AI-powered exoskeleton control systems.
- 2023: Acquisition of a smaller exoskeleton company by a large medical device manufacturer.
In-Depth Exoskeleton Industry Market Outlook
The exoskeleton market is poised for significant growth, driven by technological advancements, increasing healthcare spending, and expanding applications. Future market potential is substantial, particularly in emerging markets and new application areas. Strategic partnerships and continued innovation will be key to capturing market share and driving long-term success.
Exoskeleton Industry Segmentation
-
1. Treatment Type
- 1.1. Rehabilitation
- 1.2. Augmentation
-
2. Body Part Type
- 2.1. Upper Body
- 2.2. Lower Body
-
3. Product Type
- 3.1. Stationary
- 3.2. Mobile
Exoskeleton Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Exoskeleton Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 12.50% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Demand from Healthcare Sector for Robotic Rehabilitation; Advancement in Robotic Technologies; Huge Investment for the Development of the Exoskeleton Technology
- 3.3. Market Restrains
- 3.3.1. Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines
- 3.4. Market Trends
- 3.4.1. The Mobile Segment is Expected to Hold the Largest Share by Product Type Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 5.1.1. Rehabilitation
- 5.1.2. Augmentation
- 5.2. Market Analysis, Insights and Forecast - by Body Part Type
- 5.2.1. Upper Body
- 5.2.2. Lower Body
- 5.3. Market Analysis, Insights and Forecast - by Product Type
- 5.3.1. Stationary
- 5.3.2. Mobile
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6. North America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6.1.1. Rehabilitation
- 6.1.2. Augmentation
- 6.2. Market Analysis, Insights and Forecast - by Body Part Type
- 6.2.1. Upper Body
- 6.2.2. Lower Body
- 6.3. Market Analysis, Insights and Forecast - by Product Type
- 6.3.1. Stationary
- 6.3.2. Mobile
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7. Europe Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7.1.1. Rehabilitation
- 7.1.2. Augmentation
- 7.2. Market Analysis, Insights and Forecast - by Body Part Type
- 7.2.1. Upper Body
- 7.2.2. Lower Body
- 7.3. Market Analysis, Insights and Forecast - by Product Type
- 7.3.1. Stationary
- 7.3.2. Mobile
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8. Asia Pacific Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8.1.1. Rehabilitation
- 8.1.2. Augmentation
- 8.2. Market Analysis, Insights and Forecast - by Body Part Type
- 8.2.1. Upper Body
- 8.2.2. Lower Body
- 8.3. Market Analysis, Insights and Forecast - by Product Type
- 8.3.1. Stationary
- 8.3.2. Mobile
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9. Middle East and Africa Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9.1.1. Rehabilitation
- 9.1.2. Augmentation
- 9.2. Market Analysis, Insights and Forecast - by Body Part Type
- 9.2.1. Upper Body
- 9.2.2. Lower Body
- 9.3. Market Analysis, Insights and Forecast - by Product Type
- 9.3.1. Stationary
- 9.3.2. Mobile
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10. South America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10.1.1. Rehabilitation
- 10.1.2. Augmentation
- 10.2. Market Analysis, Insights and Forecast - by Body Part Type
- 10.2.1. Upper Body
- 10.2.2. Lower Body
- 10.3. Market Analysis, Insights and Forecast - by Product Type
- 10.3.1. Stationary
- 10.3.2. Mobile
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 11. North America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Europe Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 Germany
- 12.1.2 United Kingdom
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Rest of Europe
- 13. Asia Pacific Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 Australia
- 13.1.5 South Korea
- 13.1.6 Rest of Asia Pacific
- 14. Middle East and Africa Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 GCC
- 14.1.2 South Africa
- 14.1.3 Rest of Middle East and Africa
- 15. South America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Parker-Hannifin Corp
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 B-Temia Inc
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Rewalk Robotics
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Rehab-Robotics Company Limited
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Gogoa Mobility Robots
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Bioservo Technologies AB
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Bionik Laboratories Corp
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Cyberdyne Inc
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Ekso Bionics Holdings
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Bioness Inc
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.1 Parker-Hannifin Corp
List of Figures
- Figure 1: Global Exoskeleton Industry Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: North America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 3: North America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 4: Europe Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 5: Europe Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 6: Asia Pacific Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 7: Asia Pacific Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 8: Middle East and Africa Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 9: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 11: South America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 12: North America Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 13: North America Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 14: North America Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 15: North America Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 16: North America Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 17: North America Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 18: North America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 19: North America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 20: Europe Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 21: Europe Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 22: Europe Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 23: Europe Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 24: Europe Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 25: Europe Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 26: Europe Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 27: Europe Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 29: Asia Pacific Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 30: Asia Pacific Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 31: Asia Pacific Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 32: Asia Pacific Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 33: Asia Pacific Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 34: Asia Pacific Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 35: Asia Pacific Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 36: Middle East and Africa Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 37: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 38: Middle East and Africa Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 39: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 40: Middle East and Africa Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 41: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 42: Middle East and Africa Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 43: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 44: South America Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 45: South America Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 46: South America Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 47: South America Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 48: South America Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 49: South America Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 50: South America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 51: South America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Exoskeleton Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 3: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 4: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 5: Global Exoskeleton Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 7: United States Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Canada Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Mexico Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 11: Germany Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: United Kingdom Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: France Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Italy Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 15: Spain Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Rest of Europe Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 18: China Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Japan Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: India Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Australia Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: South Korea Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Rest of Asia Pacific Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 25: GCC Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: South Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Rest of Middle East and Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 29: Brazil Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Argentina Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 31: Rest of South America Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 33: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 34: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 35: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 36: United States Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: Canada Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Mexico Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 40: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 41: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 42: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 43: Germany Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: United Kingdom Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: France Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: Italy Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 47: Spain Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: Rest of Europe Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 49: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 50: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 51: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 52: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 53: China Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: Japan Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 55: India Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Australia Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 57: South Korea Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Rest of Asia Pacific Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 59: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 60: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 61: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 62: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 63: GCC Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: South Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 65: Rest of Middle East and Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 66: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 67: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 68: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 69: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 70: Brazil Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 71: Argentina Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 72: Rest of South America Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Exoskeleton Industry?
The projected CAGR is approximately 12.50%.
2. Which companies are prominent players in the Exoskeleton Industry?
Key companies in the market include Parker-Hannifin Corp, B-Temia Inc, Rewalk Robotics, Rehab-Robotics Company Limited, Gogoa Mobility Robots, Bioservo Technologies AB, Bionik Laboratories Corp, Cyberdyne Inc, Ekso Bionics Holdings, Bioness Inc.
3. What are the main segments of the Exoskeleton Industry?
The market segments include Treatment Type, Body Part Type, Product Type.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Growing Demand from Healthcare Sector for Robotic Rehabilitation; Advancement in Robotic Technologies; Huge Investment for the Development of the Exoskeleton Technology.
6. What are the notable trends driving market growth?
The Mobile Segment is Expected to Hold the Largest Share by Product Type Over the Forecast Period.
7. Are there any restraints impacting market growth?
Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Exoskeleton Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Exoskeleton Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Exoskeleton Industry?
To stay informed about further developments, trends, and reports in the Exoskeleton Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence